Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia (JEWEL I)

Viatris

Status and phase: Completed; Phase 3

Conditions: Hypertension; Dyslipidemia

Treatments: Drug: Amlodipine/Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00330785

A3841018

Details and patient eligibility

About

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are above target LDL-C and BP who are eligible for treatment

Exclusion criteria

• High liver enzymes

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)